U.S. FDA expert panel weighs Novavax COVID vaccine

By Michael Erman and Manas Mishra (Reuters) -Advisers to the U.S. Food and Drug Administration on Tuesday will vote on whether to recommend authorizing Novavax Inc’s COVID-19 vaccine, which the drugmaker hopes can become the shot of choice among some A…